DBV Technologies DBVT
NASDAQ DBVT
$13.52 -0.18 (-1.31%)
As of: Sep 4, 2026 · 2:32 PM EDT

DBV Technologies (DBVT) Profit After Tax (2020 - 2026)

DBV Technologies (DBVT) posted Profit After Tax of -$51.2 million for Q2 2026, down 7.56% sequentially from -$47.6 million in Q1 2026, and down 22.2% YoY from -$65.8 million in Q2 2025.

Analysis

DBV Technologies (DBVT) Profit After Tax (2020 - 2026) Analysis & Trends

DBV Technologies has reported Profit After Tax for 7 years, with the latest figure at -$51.2 million in Q2 2026.

  • Quarterly Profit After Tax fell 22.2% year-over-year to -$51.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$177.6 million (down 40.66% YoY) and the FY2025 annual result came in at -$146.9 million, down 24.56% from the prior year.
  • Profit After Tax fell to -$51.2 million in Q2 2026 per DBVT's latest filing, from -$47.6 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$10.6 million in Q4 2023 and troughed at -$51.2 million in Q2 2026.
  • A 5-year average of -$29.5 million and a median of -$27.2 million in 2024 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2023 and 2024: Profit After Tax surged 43.9% in 2023, then slumped 152.84% in 2024.
  • Over 5 years, Profit After Tax stood at -$18.9 million in 2022, then soared by 43.9% to -$10.6 million in 2023, then plunged by 152.84% to -$26.8 million in 2024, then slumped by 67.03% to -$44.8 million in 2025, then declined by 14.21% to -$51.2 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$51.2 million, -$47.6 million, and -$44.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -644.37 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 81.49 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -16.62 Mn
10 DBV Technologies 5.86 Bn 5.69 Bn - -51.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.20 Mn
Mar 31, 2026 -47.60 Mn
Dec 31, 2025 -44.83 Mn
Sep 30, 2025 -34.00 Mn
Jun 30, 2025 -41.90 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 -26.84 Mn
Sep 30, 2024 -30.44 Mn
Jun 30, 2024 -33.12 Mn
Mar 31, 2024 -27.35 Mn
Dec 31, 2023 -10.62 Mn
Sep 30, 2023 -20.66 Mn
Jun 30, 2023 -24.24 Mn
Mar 31, 2023 -20.56 Mn
Dec 31, 2022 -18.92 Mn
Sep 30, 2022 -32.67 Mn
Jun 30, 2022 -23.04 Mn
Mar 31, 2022 -16.71 Mn
Dec 31, 2021 -16.24 Mn
Sep 30, 2021 -27.73 Mn